Scientists have discovered a way to distinguish pancreatic cancer from non-cancerous tissue, new research shows. The method may also distinguish patients who will survive longer than two years.
Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment. In the largest study of its kind, research led by the University of Edinburgh, analyzed hospital treatment and outcomes for 44,372 patients admitted to 113 hospitals in 14 countries with heart attacks or unstable angina (threatened heart attacks).
Variants of two genes involved in the inflammatory system appear to protect patients from suffering a decline in mental function following heart surgery.
The American Cancer Society and the National Palliative Care Research Center (NPCRC) are awarding $1.5 million in research grants to researchers at ten institutions for studies aimed at reducing suffering for seriously ill patients and their family caregivers. The studies will be conducted over the next two years.
Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment, revealed by Edinburgh researchers.
A promising anti-inflammatory drug failed to improve symptoms of moderate to severe chronic obstructive pulmonary disease, or COPD, in a large, multicenter trial.
With the growing concerns of children?s exposure to secondhand smoke, it has become more critical than ever to involve health care providers such as pediatricians in educating parents about the potential hazardous health consequences.
Migraine or chronic headache in teens and young children may boost psychiatric disorders and suicidal tendencies, revealed by the researchers from Taiwan.
Falls from ladders can result in serious injury and affect people of all ages. The general public is at risk for ladder injuries, yet receives little, if any, instruction on ladder use and safety.
GlaxoSmithKline (GSK) and The Wellcome Trust today announced a collaboration to develop a new class of antibacterial to combat the rise of certain drug-resistant hospital-acquired infections, including those that lead to pneumonia.